Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2022 Earnings Conference Call March 16, 2023 8:00 AM ET

Company Participants

Robert Shawah - Co-Founder & Chief Financial Officer

David Luci - President & Chief Executive Officer

Conference Call Participants

Jason McCarthy - Maxim

James Molloy - Alliance Global Partners

Operator

Greetings and welcome to the Acurx Pharmaceutical Fourth Quarter and Full Year 2022 Financial Results and Business Update. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Robert Shawah, Chief Financial Officer. Thank you, Robert. You may begin.

Robert Shawah

Good morning. Thank you and welcome to our call. This morning, we issued a press release providing financial results and company highlights for the fourth quarter and fiscal year 2022. This press release is available on our website at acarexpharmaceuticals.com. Joining me today is Dave Luci, President and CEO of Acurx. Who'll give a corporate update and outlook for 2023. After that, I'll provide some highlights of the financials from the quarter and the year ended December 31, 2022 and then turn the call back to Dave for his closing remarks.

As a reminder, during today's call, we'll be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions, estimates and projections about future events that are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Investors should consider these risks and other information described in our filings made with the Securities and Exchange Commission, including our annual report on Form 10-K which we filed on Wednesday, March 15, 2023. You are cautioned not to place undue reliance on these forward-looking statements and Acurx disclaims any obligation to update such statements at any time in the future. This conference call contains time-sensitive information that's accurate only as of the date of this live broadcast today, March 16, 2023. Acurx undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date and time of this conference call.

I'll now turn the call over to Dave Luci. Dave?

David Luci

Thanks, Rob. Good morning, everyone and thanks for joining us on this conference call to review our financial results for the fourth quarter and year ended 12/31/2022. And also I'll cover some recent updates and then we'd be pleased to take any questions.